News | February 27, 2014

China Announces Claim Coverage Electrode-Based Ablation Balloon to Treat Atrial Fibrillation

Ablation Systems Balloon Atrial Fibrillation Therapies EP Lab Apama Shifamed

February 27, 2014 — Apama Medical is a privately held medical device company formed by Shifamed's medical incubator. It received Chinese notice of allowance for claims covering their low profile electrode assembly that enables the attachment of flexible electrodes to an ablation balloon for energy delivery and monitoring. The Chinese patent will complement an existing patent (U.S. Patent No. 8,295,902) giving Apama broad claim coverage for electrode-based ablation balloons in the United States and China for the treatment of atrial fibrillation (AF). Utilizing this patented electrode technology enables Apama to design an ablation catheter that performs a full pulmonary vein (PV) ablation and rotor ablation in a single-shot.

The global electrophysiology (EP) mapping and ablation market is estimated to reach $4.3 billion in 2017 and is the fastest growing cardiac rhythm management market segment. Worldwide catheter based AF ablation is estimated to grow from 180,000 procedures in 2009 up to 827,000 procedures by 2017. Fundamental barriers to adoption of AF ablation procedures have been attributed to technical complexity and length of procedure time. As a result, there is a large underserved market.

For more information: www.shifamed.com


Related Content

News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
News

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022
Home
News

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
Subscribe Now